Life,
Journal Year:
2024,
Volume and Issue:
14(12), P. 1571 - 1571
Published: Nov. 29, 2024
Background:
Pregnancy
has
been
identified
as
a
risk
factor
for
severe
COVID-19,
leading
to
maternal
and
neonatal
complications.
The
safety
effects
of
the
SARS-CoV-2
vaccination
during
pregnancy,
particularly
on
placental
function
oxidative
stress
(OxS),
remain
underexplored.
We
investigated
impact
third-trimester
antioxidant
defense
markers.
Methods:
Ninety
full-term
pregnant
women
were
divided
into
following
groups:
vaccinated
(n
=
27)
unvaccinated
25)
COVID-19-positive
women;
control
subgroups
composed
19)
or
COVID-19-negative
with
healthy
term
singleton
pregnancy
no
signs
COVID-19.
Placental
samples
collected
after
delivery.
Lipid
peroxidation
(TBARS),
gene
expression
HIF-1α,
catalase
(CAT),
superoxide
dismutase-1
(SOD1)
CAT-SOD1
enzymatic
activity
measured.
Results:
placentae
exhibited
significantly
higher
TBARS
HIF-1α
levels
compared
controls,
regardless
status.
Vaccination
increased
CAT
SOD1
in
women,
suggesting
enhanced
defense.
Unvaccinated
showed
incidence
COVID-19
symptoms
lower
enzyme
activity.
Conclusions:
infection
induced
OxS,
which
is
countered
by
adaptive
response.
enhances
defense,
further
supporting
benefits
preventing
complications
protecting
fetal
development.
Journal of Medical Virology,
Journal Year:
2022,
Volume and Issue:
95(1)
Published: Aug. 27, 2022
Abstract
Observational
studies
have
reported
high
comorbidity
between
type
2
diabetes
(T2D)
and
severe
COVID‐19.
However,
the
causality
T2D
COVID‐19
has
yet
to
be
validated.
We
performed
genetic
correlation
Mendelian
randomization
(MR)
analyses
assess
relationships
potential
causal
associations
three
outcomes
(severe
acute
respiratory
syndrome
coronavirus
[SARS‐CoV‐2]
infection,
hospitalization,
critical
COVID‐19).
Molecular
pathways
connecting
SARS‐CoV‐2
were
reconstructed
extract
insights
into
mechanisms
underlying
connection.
identified
a
overlap
each
outcome
(genetic
correlations
0.21–0.28).
The
MR
indicated
that
liability
confers
effect
on
hospitalized
(odds
ratio
1.08,
95%
confidence
interval
[CI]
1.04–1.12)
(1.09,
1.03–1.16),
while
infection
exerts
(1.25,
1.00–1.56).
There
was
suggestive
evidence
associated
with
an
increased
risk
for
(1.02,
1.00–1.03),
(1.06,
1.00–1.13)
0.99–1.19)
T2D.
Pathway
analysis
panel
of
immunity‐related
genes
may
mediate
links
at
molecular
level.
Our
study
provides
robust
support
bidirectional
contribute
amplifying
severity
COVID‐19,
increase
Biological Trace Element Research,
Journal Year:
2021,
Volume and Issue:
200(9), P. 3945 - 3956
Published: Nov. 5, 2021
Abstract
Several
studies
have
indicated
that
selenium
deficiency
may
be
detrimental
in
the
context
of
various
viral
disorders,
and
case
COVID-19,
several
reported
heterogeneous
results
concerning
association
with
severity
disease.
To
summarize
available
data
surrounding
body
levels
outcomes
a
systematic
search
was
performed
Medline
database
(PubMed),
Scopus,
Cochrane
Library,
Embase,
Web
Science
using
keywords
including
“SARS-CoV-2,”
“COVID-19,”
“selenium,”
Studies
evaluating
COVID-19
were
included.
Among
1,862
articles
viewed
search,
10
included
after
title,
abstract,
full-text
review.
One
study
further
searching
literature
again
for
any
newly
published
articles.
Out
11
studies,
measured
serum
level,
one
investigated
urinary
level.
Three
SELENOP
level
as
well
Glutathione
peroxidase-3
also
assessed
study.
The
severity,
mortality,
risk
COVID-19.
Nine
lower
is
associated
worse
outcomes.
Two
no
significant
between
In
study,
to
higher
severe
fatal
cases
compared
non-severe
recovered
patients,
respectively.
most
cases,
outcomes,
patients
than
healthy
individuals.
Thus,
it
could
concluded
cautious
supplementation
helpful
prevent
disease
progression.
However,
randomized
clinical
trials
are
needed
confirm
this.
BMC Pregnancy and Childbirth,
Journal Year:
2022,
Volume and Issue:
22(1)
Published: Feb. 28, 2022
COVID-19
during
pregnancy
is
associated
with
adverse
outcomes
for
mother
and
fetus.
SARS-CoV-2
vaccination
has
significantly
reduced
the
risk
of
symptomatic
disease.
Several
small
studies
have
reported
safety
pregnancy,
no
effect
on
obstetric
outcomes.To
examine
association
between
maternal
neonatal
in
a
large
cohort
study.
Furthermore,
to
evaluate
if
timing
related
outcomes.A
retrospective
study
women
who
delivered
December
2020
July
2021
at
tertiary
medical
center.
Excluded
were
multiple
prior
infection
or
before
unknown
vaccination.
Primary
incidence
preterm
labor
gestational
age.
Secondary
other
complications.
A
secondary
analysis
investigating
time
was
also
performed.
Multivariable
logistic
regression
models
used
adjust
potential
confounders.There
5618
met
inclusion
criteria:
2,305
(41%)
vaccinated
3,313
(59%)
unvaccinated.
There
differences
non-vaccinated
patients
respect
primary
outcomes.
The
rate
birth
5.5%
group
compared
6.2%
unvaccinated
(p
=
0.31).
Likewise,
rates
age
comparable
two
groups
(6.2%
vs.
7.0%
respectively,
p
0.2).
In
focusing
its
relationship
outcomes,
second
trimester
(n
964)
third
1329)
independently
their
counterparts.
Women
more
likely
(8.1%
6.2%,
<
0.001).
This
persisted
after
adjusting
confounders
(adjusted
odds
ratio
1.49,
95%CI
1.11,
2.01).SARS-CoV-2
vaccine
appears
be
safe
increase
women.
However,
there
may
an
birth.
Human Reproduction Update,
Journal Year:
2023,
Volume and Issue:
30(2), P. 133 - 152
Published: Nov. 28, 2023
Abstract
BACKGROUND
Pregnant
women
infected
with
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
are
more
likely
to
experience
preterm
birth
and
their
neonates
be
stillborn
or
admitted
a
neonatal
unit.
The
World
Health
Organization
declared
in
May
2023
an
end
the
disease
2019
(COVID-19)
pandemic
as
global
health
emergency.
However,
pregnant
still
becoming
SARS-CoV-2
there
is
limited
information
available
regarding
effect
of
infection
early
pregnancy
on
outcomes.
OBJECTIVE
AND
RATIONALE
We
conducted
this
systematic
review
determine
prevalence
loss
SARS-Cov-2
compare
risk
without
infection.
SEARCH
METHODS
Our
based
prospectively
registered
protocol.
search
PregCov19
consortium
was
supplemented
extra
electronic
specifically
up
10
March
PubMed,
Google
Scholar,
LitCovid.
included
retrospective
prospective
studies
infection,
provided
that
they
contained
losses
first
and/or
second
trimester.
Primary
outcome
miscarriage
defined
before
20
weeks
gestation,
however,
reported
22
24
were
also
included.
Additionally,
we
report
occur
at
trimester
specifying
gestational
age,
for
only
when
study
presented
stillbirths
foetal
separately
from
miscarriages.
Data
stratified
into
Secondary
outcomes
ectopic
(any
extra-uterine
pregnancy),
termination
pregnancy.
At
least
three
researchers
independently
extracted
data
assessed
quality.
calculated
odds
ratios
(OR)
differences
(RDs)
corresponding
95%
CI
pooled
using
random
effects
meta-analysis.
To
estimate
prevalence,
performed
meta-analysis
proportions.
Heterogeneity
by
I2.
OUTCOMES
120
comprising
total
168
444
infection;
which
18
233
Evidence
level
considered
low
moderate
certainty,
mostly
owing
selection
bias.
did
not
find
evidence
association
between
(OR
1.10,
0.81–1.48;
I2
=
0.0%;
RD
0.0012,
−0.0103
0.0127;
0%;
9
studies,
4439
women).
Miscarriage
occurred
9.9%
(95%
6.2–14.0%;
68%;
46
1797
women)
SARS
CoV-2
1.2%
0.3–2.4%;
34%;
33
studies;
3159
proportion
pregnancies
1.4%
0.02–4.2%;
66%;
14
950
Termination
0.6%
0.01–1.6%;
79%;
39
1166
WIDER
IMPLICATIONS
found
no
indication
increases
provide
better
estimates,
well-designed
needed
include
conception
consider
clinical
manifestation
severity
loss,
well
potential
confounding
factors
such
previous
loss.
For
practice,
should
advised
take
precautions
avoid
exposure
receive
vaccination.
Journal of Medical Virology,
Journal Year:
2021,
Volume and Issue:
94(3), P. 1074 - 1084
Published: Oct. 29, 2021
The
aim
of
this
study
is
to
share
the
comprehensive
experience
a
tertiary
pandemic
center
on
pregnant
women
with
COVID-19
and
compare
clinical
outcomes
between
pregnancy
trimesters.
present
prospective
cohort
consisted
who
were
followed
up
at
Ankara
City
Hospital
March
11,
2020
February
20,
2021.
Clinical
characteristics
perinatal
compared
A
total
1416
(1400
singletons
16
twins)
evaluated.
Twenty-six
(1.8%)
patients
admitted
intensive
care
unit
(ICU)
maternal
mortality
was
observed
in
six
(0.4%)
cases.
Pregnancy
complications
227
(16.1%)
cases
preterm
labor
most
common
one
(n
=
42,
2.9%).
There
311,
433,
672
first,
second,
third
trimesters
pregnancy,
respectively.
Rates
mild
severe/critic
highest
first
second
trimesters,
hospitalization
rate
trimester.
complications,
mortality,
NICU
admission
rates
similar
groups.
course
disease
obstetric
may
be
different
among
worse
even
without
any
coexisting
health
problems.
Journal of Obstetrics and Gynaecology Research,
Journal Year:
2022,
Volume and Issue:
49(3), P. 912 - 919
Published: Dec. 29, 2022
To
investigate
the
association
of
systemic
immune-inflammation
index
(SII)
and
immune-response
(SIRI)
with
adverse
perinatal
outcomes
in
pregnant
women
coronavirus
disease
2019
(COVID-19).The
cases
were
divided
into
(1)
Mild-moderate
COVID-19
group
(n
=
2437)
(2)
Severe-critical
212).
Clinical
characteristics,
outcomes,
SII
(neutrophilXplatelet/lymphocyte),
SIRI
(neutrophilXmonocyte/lymphocyte)
compared
between
groups.
Afterward,
values
subgroups
based
on
pregnancy
complications,
neonatal
intensive
care
unit
(NICU)
admission,
maternal
mortality.
A
receiver
operator
characteristic
analysis
was
performed
for
determination
optimal
cutoff
prediction
severity,
NICU
mortality.Both
significantly
higher
complicated
(p
<
0.05).
Cutoff
severe-critical
1309.8
SII,
2.3
SIRI.
For
973.2
1.6.
1045.4
1.8
calculated
admission.
Finally,
cut-off
1224.2
2.4
found
mortality.SII
might
be
used
combination
other
clinical
findings
poor
outcomes.
PLoS ONE,
Journal Year:
2023,
Volume and Issue:
18(5), P. e0284773 - e0284773
Published: May 5, 2023
The
COVID-19
pandemic
has
impacted
public
and
private
health
systems
around
the
world,
impairing
good
practices
in
women's
care.
However,
little
is
known
about
experiences,
knowledge,
feelings
of
Brazilian
women
this
period.
objective
was
to
analyze
experiences
women,
seen
at
maternity
hospitals
accredited
by
Unified
Health
System
(SUS,
acronym
Portuguese),
regarding
care
during
pregnancy,
childbirth,
postpartum
periods,
their
interpersonal
relationships,
perceptions
pandemic.
This
a
qualitative,
exploratory
research,
carried
out
three
municipalities
with
hospitalized
2020,
or
period,
not.
For
data
collection,
semi-structured
individual
interviews
(in
person,
telephone,
digital
platform)
were
conducted,
recorded
transcribed.
content
analysis
thematic
modalities
displayed
as
per
following
axes:
i)
Knowledge
disease;
ii)
Search
for
prenatal,
periods;
iii)
Experience
suffering
from
COVID-19;
iv)
Income
work;
v)
Family
dynamics
social
support
network.
A
total
46
interviewed
São
Luís-MA,
Pelotas-RS,
Niterói-RJ.
Use
media
important
convey
information
fight
fake
news.
negatively
access
contributing
worsening
population's
economic
vulnerabilities.
Women
experienced
diverse
manifestations
disease,
psychic
disorders
very
frequent.
Social
isolation
disrupted
network
these
who
found
strategies
communication
technologies.
Women-centered
care-including
qualified
listening
mental
support-can
reduce
severity
cases
pregnant,
parturient,
women.
Sustainable
employment
income
maintenance
policies
are
essential
mitigate
vulnerabilities
risks
Journal of Infection and Public Health,
Journal Year:
2022,
Volume and Issue:
15(2), P. 270 - 276
Published: Jan. 17, 2022
In
the
era
of
coronavirus
disease
2019
(COVID-19)
pandemic,
there
is
a
paucity
information
regarding
actual
prevalence
COVID-19
in
pregnant
women
compared
to
non-pregnant
women.
The
purpose
this
study
was
investigate
infection
and
clinical
outcome
women.This
nationwide
cross-sectional
South
Korea
between
January
2020
February
2021
using
claim
database.
primary
women,
secondary
occurrence
severe
illness
among
infected
patients.
Severity
classified
into
four
categories
according
WHO
ordinal
scale.The
lower
than
aged
20-44
(0·02%
vs.
0.14%,
p
<
0.0001).
However,
positive
at
age
20-44,
higher
risk
oxygen
therapy
after
hospitalization
(score
4
scale:
6.4%
1.6%,
0.05).
There
were
no
deaths
or
hospitalized
with
COVID-19,
although
majority
them
(96·2%)
admitted
hospital.
On
other
hand,
42·3%
hospital
0.04%
died
0.1%
had
disease.The
Korea,
resulting
relatively
small
cases
fatality.
It
has
implications
that
public
health
policy,
such
as
an
effective
response
powerful
preemptive
strategy
for
can
better
outcomes
COVID-19.
Echocardiography,
Journal Year:
2022,
Volume and Issue:
39(6), P. 803 - 810
Published: May 20, 2022
Abstract
Aim
We
aimed
to
examine
fetal
cardiac
output
(CO)
in
patients
who
recovered
from
severe
acute
respiratory
syndrome
Coronavirus
2
(SARS‐CoV‐2)
infection.
Materials
This
prospective
study
included
48
pregnant
women
SARS‐CoV‐2
infection
and
50
control
cases.
was
diagnosed
by
polymerase
chain
reaction
(PCR)
test
patients.
Fetal
echocardiographic
evaluations
were
performed
at
24–37
weeks
of
gestation
the
group.
Results
The
median
value
ultrasound
evaluation
34
(2.6)
recovery
(RSI)
group,
32
(7.6)
group
(
p
=
.565).
Left
(LCO)
z
score
significantly
lower
RSI
than
.041).
LCO
combine
(CCO)
disease
mild,
moderate
groups,
controls
.019
.013).
CCO
(ml/min/kg)
decreased
when
compared
with
mild
groups
.044).
Conclusion
In
present
study,
found
be
reduced
those
disease,
while
there
no
significant
difference
Placental
dysfunction
inflammatory
cytokines
might
cause
changes.
Further
studies
could
clarified
on
impact
function.